Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.

Exploring the Connection Between BDNF/TrkB and AC/cAMP/PKA/CREB Signaling Pathways: Potential for Neuroprotection and Therapeutic Targets for Neurological Disorders

Gupta, Abhishek Kumar, Gupta, Sumedha, Mehan, Sidharth, Khan, Zuber, Das Gupta, Ghanshyam, Narula, Acharan S. · 2025 · Molecular Neurobiology

Abstract

The BDNF/TrkB and AC/cAMP/PKA/CREB signaling pathways play a vital role in neuroplasticity, neuronal survival, and cognitive functions. This review explores its physiological and pathological implications in neurological disorders, with a focus on neurodegenerative diseases (NDDs) and neuropsychiatric disorders (NPDs). Neurological conditions increasingly burden public health, making understanding the biochemical mechanisms that underpin these diseases critical. BDNF, a neurotrophic factor, binds to the TrkB receptor, activating multiple intracellular signaling cascades that regulate cellular responses essential for neurogenesis, memory, and learning. Dysregulation within this pathway has been linked to various NDDs, as well as NPDs. Key components of the path, including adenylyl cyclase and cyclic AMP, mediate the effects of neurotransmitters and growth factors, influencing downstream targets like PKA and CREB, which are crucial for gene expression and synaptic changes. Furthermore, the review discusses the challenges of targeting this pathway for therapeutic interventions, including receptor isoform diversity, blood-brain barrier penetration, and potential side effects. Future strategies may include the development of selective TrkB modulators, nanoparticle carriers for drug delivery, and innovative gene therapy techniques. Advancing the understanding of this complex signaling network holds promise for effective interventions in treating neurological and psychiatric disorders, ultimately enhancing neuroprotection and cognitive resilience.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12035-025-05001-5

Cites

217 of 217 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 217 references

Research works printed but not linked: 39

  1. Mukherjee R, Rana R, Mehan S, Khan Z, Das Gupta G, Narula AS et al (2025) Investigating the interplay between the Nrf2/Keap1/HO-1/SIRT-1 pathway and the p75NTR/PI3K/Akt/MAPK cascade in neurological disorders: mechanistic insights and therapeutic innovations. Molecular Neurobiology. Springer
  2. Carroll WM (2023) Evidence Into. Policy 19(3):255–265
  3. Sharma H, Chandra P, Pathak R, Bhandari M (2024) Advancements in the therapeutic approaches to treat neurological disorders. Cahiers Magellanes-Ns. 6(2):4328–89
  4. Sharma H, Anand A, Halagali P, Inamdar A, Pathak R, Taghizadeh-Hesary F, Ashique S (2024) Advancement of nanoengineered flavonoids for chronic metabolic diseases. Role Flav Chron Metabol Dis Bench Clin 18:459–510
  5. Prajapati C, Rai SN, Singh AK, Chopade BA, Singh Y, Singh SK et al (2025) An update of fungal endophyte diversity and strategies for augmenting therapeutic potential of their potent metabolites: recent advancement. Appl Biochem Biotechnol 5:1–68
  6. Kocik RA, Gasch AP (2022) Breadth and specificity in pleiotropic protein kinase A activity and environmental responses. Front Cell Dev Biol 10(February):1–11
  7. Wang H, Xu J, Lazarovici P, Quirion R, Zheng W (2018) cAMP response element-binding protein (CREB): a possible signaling molecule link in the pathophysiology of schizophrenia. Front Mol Neurosci 11(August):1–14
  8. Mehan S, Dudi R, Rajput M, Ghimire K (2018) Investigation of transcription factor cyclic AMP response element-binding protein activator in rodent model of intracerebral hemorrhage. Ann Clin Pharmacol Toxicol 1(1):ACPT-01-1003. https://www.medtextpublications.com/annals-of-clinical-pharmacology-toxicology-articles-in-press.php
  9. Chowdhury MAR, Haq MM, Lee JH, Jeong S (2024) Multi-faceted regulation of CREB family transcription factors. Front Mol Neurosci 17(August):1–18
  10. Sharma H, Al Noman A, Alam S, Tonni SD (2025) Plants as medicine for autism: reviewing the evidence for phytopharmaceuticals for ASD. Curr Bioact Compd 21:1–17. https://doi.org/10.2174/0115734072347775250129042526 · DOI
  11. Sanabra C, Mengod G (2011) Neuroanatomical distribution and neurochemical characterization of cells expressing adenylyl cyclase isoforms in mouse and rat brain. J Chem Neuroanat 41(1):43–54 · DOI · Paper page
  12. Maghsoudi S, Shuaib R, Van Bastelaere B, Dakshinamurti S (2024) Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles. Front Pharmacol 15(April):1–23
  13. Giacoletti G, Price T, Hoelz LVB, Shremo Msdi A, Cossin S, Vazquez-Falto K et al (2022) A selective adenylyl cyclase 1 inhibitor relieves pain without causing tolerance. Front Pharmacol 13(July):1–12
  14. Guo R, Liu T, Shasaltaneh MD, Wang X, Imani S, Wen QL (2022) Targeting adenylate cyclase family: new concept of targeted cancer therapy. Front Oncol 12(June):1–15
  15. Sugo N, Morimatsu M, Arai Y, Kousoku Y, Ohkuni A, Nomura T et al (2014) Single-molecule imaging reveals dynamics of CREB transcription factor bound to its target sequence. Sci Rep 2015(5):1–9
  16. Sharma H, Halagali P, Majumder A, Sharma V, Pathak R (2024) Natural compounds targeting signaling pathways in breast cancer therapy. Afr J Biol Sci 6(10):5430–79
  17. Ida DJ& Y (2020) Journal of Population Therapeutics. ResearchgateNet [Internet]. 27(October):19–22. Available from: https://www.researchgate.net/profile/Amar-Thakare/publication/354153623_Arabian_undergraduates_perceptions_regarding_barriers_among_the_geriatric_patients_for_failing_to_keep_dental_appointments_A_cross-sectional_study/links/6127ef3d0360302a005f3b37/Arabi
  18. Pathak R, Sharma S, Bhandari M, Nogai L, Mishra R, Saxena A et al (2024) Neuroinflammation at the crossroads of metabolic and neurodegenerative diseases: causes, consequences and interventions. J Exp Zoology India 27(2):2447–2461
  19. Numakawa T, Kajihara R (2023) Involvement of brain-derived neurotrophic factor signaling in the pathogenesis of stress-related brain diseases. Front Mol Neurosci 16(September):1–15
  20. Schirò G, Iacono S, Ragonese P, Aridon P, Salemi G, Balistreri CR (2022) A brief overview on BDNF-Trk pathway in the nervous system: a potential biomarker or possible target in treatment of multiple sclerosis? Front Neurol 13(July):1–14
  21. Angelica MD, Fong Y (2008) Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity and disease. Dev Neurobiol 141(4):520–529
  22. Pradhan J, Noakes PG, Bellingham MC (2019) The role of altered BDNF/TrkB signaling in amyotrophic lateral sclerosis. Front Cell Neurosci 13(August):1–16
  23. Sharma H, Chandra P (2024) Effects of natural remedies on memory loss and Alzheimer’s disease. Afr J Biol Sci 6(7):187–211
  24. Zhang Z, Li H, Su Y, Ma J, Yuan Y, Yu Z et al (2022) Neuroprotective effects of a cholecystokinin analogue in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinson’s disease mouse model. Front Neurosci 16(March):1–14
  25. Sadek MA, Kandil EA, El Sayed NS, Sayed HM, Rabie MA (2022) Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway. Int Immunopharmacol 2023(115):109647
  26. Hassab LY, Abbas SS, Mohammed RA, Abdallah DM (2023) Dimethyl fumarate abrogates striatal endoplasmic reticulum stress in experimentally induced late-stage Huntington’s disease: focus on the IRE1α/JNK and PERK/CHOP trajectories. Front Pharmacol 14(March):1–13
  27. Rabie MA, Ibrahim HI, Nassar NN, Atef RM (2022) Adenosine A1 receptor agonist, N6-cyclohexyladenosine, attenuates Huntington’s disease via stimulation of TrKB/PI3K/Akt/CREB/BDNF pathway in 3-nitropropionic acid rat model. Chem Biol Interact 2023(369):110288
  28. Gong G, Ganesan K, Wang Y, Zhang Z, Liu Y, Wang J et al (2023) Ononin ameliorates depression-like behaviors by regulating BDNF-TrkB-CREB signaling in vitro and in vivo. J Ethnopharmacol 2024(320):117375
  29. Yang Z, Zhao Y, Wang Y, Liu X, Jiang Y, Jiang Y et al (2023) Echinacoside ameliorates post-stroke depression by activating BDNF signaling through modulation of Nrf2 acetylation. Phytomedicine 2024(128):155433
  30. Qian L, Huang S, Liu X, Jiang Y, Jiang Y, Hu Y et al (2023) Morroniside improves the symptoms of post-stroke depression in mice through the BDNF signaling pathway mediated by MiR-409-3p. Phytomedicine 2024(123):155224
  31. Liu SZ, Yang J, Chen LL, Wang P, Lin L (2022) Tanshinone IIA ameliorates chronic unpredictable mild stress-induced depression-like behavior and cognitive impairment in rats through the BDNF/TrkB/GAT1 signaling pathway. Eur J Pharmacol 2023(938):175385
  32. Zhang S, Hu Y, Zhao Y, Feng Y, Wang X, Miao M et al (2023) Molecular mechanism of Chang Shen Hua volatile oil modulating brain cAMP-PKA-CREB pathway to improve depression-like behavior in rats. Phytomedicine 2024(130):155729
  33. Mehan S, Kumar A, Sharma T (2024) Therapeutic efficacy of Genistein in activation of neuronal AC / cAMP / CREB / PKA and mitochondrial ETC-Complex pathways in experimental model of autism : evidence from CSF, blood plasma and brain analysis. Brain Res 2024(1846):149251
  34. Uutela M, Lindholm J, Rantamäki T, Umemori J, Hunter K, Võikar V et al (2014) Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome. Front Cell Neurosci 8(MAY):1–9
  35. Seese RR, Le AA, Wang K, Cox CD, Lynch G, Gall CM (2019) A TrkB agonist and ampakine rescue synaptic plasticity and multiple forms of memory in a mouse model of intellectual disability. Neurobiol Dis 2020(134):104604
  36. Günaydın C, Arslan G, Bilge SS (2019) Proconvulsant effect of trans-cinnamaldehyde in pentylenetetrazole-induced kindling model of epilepsy: the role of TRPA1 channels. Neurosci Lett 2020(721):134823
  37. Niu J, Cao Y, Ji Y (2020) Resveratrol, a SIRT1 activator, ameliorates MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia. Front Psychiatry 11(July):1–9
  38. Sharma H, Rachamalla HK, Mishra N, Chandra P, Pathak R, Ashique S (2024) Introduction to exosome and its role in brain disorders. Exosomes Based Drug Deliv Strat Brain Disord 31:1–35
  39. Sharma H, Rani T, Khan S (2023) An insight into neuropathic pain: a systemic and up-to-date review. Int J Pharm Sci Res 14(2):607–21

Cited by

See all 72

Metadata

Authors
Gupta, A. K., Gupta, S., Mehan, S., Khan, Z., Das Gupta, G., & Narula, A. S.
Affiliations
  • Punjab Technical University (IN)
  • Indo Soviet Friendship College of Pharmacy (IN)
Corresponding author
Mehan, Sidharth
Venue
Molecular Neurobiology
Published
2025-05-09
Volume
62
Issue
11
Pages
14627-14659
ISSN
  • 0893-7648 (ISSN-L)
  • 1559-1182
OpenAlex
W4410196581
Cited by
59
References
217
Citations by year
2026: 46 · 2025: 12
FWCI
6.99
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Molecular Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Science and Engineering Research Board (DST-SERB, CRG (Core Research Grant), Grant Number: CRG/2021/001009)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
Keywords
BDNF/TrkB signaling, neuroprotection, neurodegenerative diseases, neuropsychiatric disorders, neuroplasticity, adenylate cyclase, cyclic AMP, protein kinase A, CREB, nanoparticle drug delivery, gene therapy, blood-brain barrier, cognitive resilience
MeSH terms
Neuroprotection, Cyclic AMP, Adenylyl Cyclases, Animals, Humans, Nervous System Diseases, Signal Transduction, Cyclic AMP Response Element-Binding Protein, Cyclic AMP-Dependent Protein Kinases, Brain-Derived Neurotrophic Factor, Receptor, trkB

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exploring the Connection Between BDNF/TrkB and AC/cAMP/PKA/CREB Signaling Pathways: Potential for Neuroprotection and Therapeutic Targets for Neurological Disorders. https://app.cochat.ai/papers/10.1007/s12035-025-05001-5
The paper
Gupta, A. K., Gupta, S., Mehan, S., Khan, Z., Das Gupta, G., & Narula, A. S. (2025). Exploring the Connection Between BDNF/TrkB and AC/cAMP/PKA/CREB Signaling Pathways: Potential for Neuroprotection and Therapeutic Targets for Neurological Disorders. Molecular Neurobiology. https://doi.org/10.1007/s12035-025-05001-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.